Navigation Links
San Diego Based CRO Signs Agreement With UK Based Spinal Device Manufacturer

SAN DIEGO, March 16 /PRNewswire/ -- SpineMark CRO Management, a wholly-owned subsidiary of San Diego based SpineMark Corporation, recently signed an agreement with Ranier Technology, a Cambridge, England based spinal medical device manufacturer, to provide contract research support services for the Ranier CAdisc™-L clinical trial, a 3rd generation lumbar total disc replacement device for treatment of degenerative disc disease in the lumbar spine.  SpineMark CRO Management provides site recruitment including utilization of principal investigators from its network of sites, reimbursement strategy development, payor education, trial management, site training, patient recruitment, data management, monitoring, regulatory advice and general oversight to allow Ranier to effectively complete their FDA requirements for approval of new spinal devices.  

"The SpineMark CRO model provides intermediary third party oversight to ensure that the highest quality of monitoring, management and resources can be brought to bear for Ranier, as well as the patients and physicians participating in this trial," explains Marcy Rogers, President and CEO of SpineMark.

The CAdisc™-L design, materials and biomechanics represent a significant clinical advance in the treatment of degenerative disc disease in the lumbar spine.  

"I am delighted to be working with SpineMark. Their specialized dedication to clinical research in spine, their relationships, and their ability to manage various aspects of the US clinical trial process makes them a perfect fit for our study," explains Dr. Geoffrey Andrews, CEO of Ranier Technology.

SpineMark offers an international medical advisory board and access to SpineMark's network of leading physicians and surgeons across the country. The corporation is an expert in FDA regulations and protocol, offering site operations support and training, contract negotiation and financial management, regulatory and compliance oversight and marketing and media relations.  

For more information on SpineMark CRO Management visit

For more information on Ranier Technology Limited visit

SOURCE SpineMark Corporation

Back to top



SOURCE SpineMark Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Tezampanel, TorreyPines Therapeutics Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
2. PG500 Series Presented at the AACR Annual Meeting in San Diego
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
5. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentation of Zerenex (ferric citrate) for the Treatment of Hyperphosphatemia at the Upcoming American Society of Nephrology Renal Week Meeting in San Diego
6. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
7. Internationally Renowned Bariatric and Laparoscopic Surgeons To Meet in San Diego
8. Solos Endoscopy, Inc. Receives Purchase Orders from University of California, San Diego Medical Center for its MammoView(TM) Product Line
9. California American Water Celebrates No Drugs Down the Drain Week in San Diego
10. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
11. ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies
Post Your Comments:
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... has always been a country of choice for global multi-center ... Europe in 2015 were tested in phase II-III clinical ... has always been a country of choice for global multi-center phase III ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... for the care management and population health arenas, is pleased to announce that ... cost containment services, has successfully implemented the ACUITY Complete Care™ Management to back ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. Arash Moradzadeh ... Man for 2015. , Angeleno Magazine is a division of Modern Luxury, ... 1994, Modern Luxury includes more than 50 magazine titles across 15 major markets. ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announced today that it has officially launched a sleek, mobile-ready and user-centric redesigned ... his company’s new website clearly outlines the benefits that its SEO services provide ...
Breaking Medicine News(10 mins):